1[1]Catlett-Falcone R, Landowski TH, Oshiro MM, et al. Constitutive activation of stat3 signaling confers resistance to apoptosis in human U266 myeloma cells. Immunity, 1999,10:105 - 115.
2[2]Singhal S, Mehta J, Desikan R, et al. Antitumor activity of thalidomide in refractory multiple myeloma. N Engl J Med, 1999,341:1565-1571.
3[3]Davies FE, Lentzsch S, Young G, et al. Thalidomide and immunomodulatory derivatives augment natural killer cell cytotoxity in multiple myeloma. Blood, 2001,98: 210-216.
4[4]Treon SP, Mitsiades C, Mitsiades N, et al. Tumor cell expression of CD59 is associated with resistance to CD20 serotherapy in patients B-cell malignancies. J Immunother,2001,24:263-271.
5[5]Hideshima T, Richardson P, Chauhan D, et al. The proteasome inhibitor PS-341 inhibits growth , induces apoptosis, and overcomes drug resistance in human multiple myeloma cells. Cancer Res,2001,61:3071-3076.
6[6]Hideshima T, Chauhan D, Schlossman R, et al. The role of tumor necrosis factor alpha in in the pathophysiolngy of human multiple myeloma: therapeutic applications. Oncogene, 2001, 20: 4519-4527.
7[7]Podar K, Tai YT, Davies FE, et al. Vascular endothelial growth factor triggeres signaling cascades mediating multiple myeloma cell growth and migration. Blood, 2001,98: 428-435.
8[8]Tassone P, Forciniti S, Galea E, et al. Synergistic induction of growth arrest and apoptosis of human myeloma cells by the IL-6 super-antagonist Sant7 and Dexamethasone. Cell Death Differ,2000,7:327-328.
9[9]Hazlehurst LA, Damino JS, Buyaksal I, et al. Adhesion to fibronectin via beta1 integrins regulates p27kip1 levels and contributes to cell adhesion mediated drug resistance (CAM-DR).Oncogene, 2000,19: 4319-4327.
10[10]Treon SP, Mitsiades CS, Mitsiades N, et al. TRAIL/Apo 2L ligand selectively induces apoptosis and overcomes drug resistance in multiple myeloma: therapeutic applications. Blood, 2001,98: 795-804.
5Ward K A, Stewart L A, Schwarer A P. CD34+-derived CDllc^+++ BDCA -1++ CD123++ DC: expansion of a phenotypically undescribed myeloid DC1 population for use in adoptive immunotherapy. Cytotherapy, 2006, 8: 130-140.
6NakamuraS, Ohnishi K, Yoshida H, et al. Retrovirusmediated gene transfer of granulocyte colony-stimulating factor receptor (G-CSFR) cDNA into MDS cells and induction of their differentiation by G-CSF. Cytokines Cell Mol Ther, 2000, 6: 61-70.
7Shi J, Ikeda K, Fujii N, et al. Activated human umbilical cord blood dendritic cells kill tumor cells without damaging normal hematological progenitor cells. Cancer Sci, 2005, 96: 127-133.
8Chapoval A I, Tamada K, Chen L. In vitro growth inhibition of a broad spectrum of tumor cell lines by activated human dendritic cells. Blood, 2000, 95: 2346-2351.
9Vidalain P O, Azocar O, Lamouille B, et al. Measles virus induces functional TRAIl. production by human dendritic cells. J Virol, 2000, 74: 556-559.
